SAS Output

16-OCT-2019 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1613-mCRC, Adv/Met, TP vs CETIRI 1 T 0 Screening 130 148 64 7 0 0 0 11/27/2017 301 116
            148 64 7 0 0 0      
 
    2 Y 1 Trastuzumab + Pertuzumab 130 11 7 1 0 0 0 11/27/2017    
        2 Cetuximab + Irinotecan   12 6 2 0 0 0      
            23 13 3 0 0 0      
 
    3 Y 3 Crossover: Trastuz + Pertuz 130 8 5 2 0 0 0 11/27/2017    
            8 5 2 0 0 0      
 
  S1815-Biliary, Met/LocAdv, GC+CPT±Nab-paclitaxel 1 Y 1 Gem+Cisplatin+Nab-paclitaxel 268 78 78 69 44 16 3 02/07/2019 253 96
        2 Gemcitabine + Cisplatin   41 41 37 24 8 2      
            119 119 106 68 24 5      
 
Yes A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC 1 E Total Registrations   19 13 6 3 2 0 03/23/2018 366 170
            19 13 6 3 2 0      
 
No A021602-PANC, Adv PNET Blinded Cabozantinib v Placebo 1 E Total Registrations   3 3 3 2 0 0 06/11/2019 202 77
            3 3 3 2 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   4 0 0 0 0 0 07/14/2016 193 84
            4 0 0 0 0 0      
 
  EA2161-PANC, Adv Rapalog Resistant PNETs, MLN0128 1 E Total Registrations   1 0 0 0 0 0 09/06/2018 172 61
            1 0 0 0 0 0      
 
  EA2165-Anal, Stg II-III, Nivolumab after CMT 1 E Total Registrations   12 11 6 3 1 0 10/09/2018 247 119
            12 11 6 3 1 0      
 
    2 E Total Registrations   9 9 5 2 1 0 10/09/2018    
            9 9 5 2 1 0      
 
  NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy 1 E Total Registrations   10 7 3 1 0 0 04/18/2018 288 123
            10 7 3 1 0 0